Lilotomab Biosimilar - Research Grade

In stock
Only %1 left
SKU
ICH5645
Add to Compare
$710.00 - $6,900.00
Delivery Time : 4 weeks

Lilotomab Biosimilar - Research Grade

Endotoxin
≤ 1.0 EU/mg as determined by the LAL method
Purity
>90% by SDS-PAGE
Species Reactivity
Human
Target
CD37ï؟½
Concentration
5mg/ml
Isotype
IgG1 - kappa
Host
CHO Cells
Sequence
https://www.imgt.org/mAb-DB/
Buffer
ICH3002
Uniprot
P11049
Shipping Conditions
Blue ice
Background
CD37 is a tetraspanin highly expressed on mature B cells and a recurring target in B-cell malignancy research. This human IgG1, kappa antibody is an unconjugated, non-therapeutic analog of lilotomab that recognizes CD37 for functional studies. It is delivered in a low-endotoxin format suitable for in vivo experiments and manufactured in scalable milligram-to-gram amounts to support heavy-usage and high-throughput laboratories. For research use only (RUO), it can be used as a binding reference and active reagent in B-cell targeting assays, ADCC and CDC characterization, in vitro screening, and preclinical models of B-cell lymphoma and leukemia.
Purification Method
This monoclonal antibody was purified using Protein A
Formulation
Sterile, preservative-free, solution in PBS. BSA and Azide free.
Storage
This biosimilar is stable when stored at 2-8°C. For longer term storage (> 3 months) it is recommended to store this antibody at -20°C or -70°C.
Applications
Functional Assays
Application Notes
This biosimilar is for research use only (RUO): it is not for diagnostic or therapeutic procedures and cannot be purchased by patients.
Use
Products are for research use only. Not for use in diagnostic or therapeutic procedures.
Delivery Time
3-4 weeks
Write Your Own Review
You're reviewing:Lilotomab Biosimilar - Research Grade
Your Rating
Back to Top